NIH-funded research R01 grant

How early experiences and parent sensitivity affect infant cellular aging

Official title: The impact of stress and caregiver sensitivity on infant cellular aging in a population of under-resourced families: A randomized controlled trial.

Funded at University of Washington · NIH-11362274 · Data updated 2026-11-12

This project will see if a home-visiting program that boosts caregiver sensitivity can protect infants under one year from early cellular aging.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Washington
NIH-funded
Lab location1 site (Seattle, United States)
Project startJune 14, 2024
Project endMarch 31, 2029
Funding year2026
Award (this year)$514,902
NIH project number5R01NR021020-03
Project IDNIH-11362274 on NIH RePORTER

Who could benefit from this research

Could help

Parents or primary caregivers of infants under 12 months receiving pediatric care at WakeMed, especially families from under-resourced backgrounds, are the intended participants.

Less likely to help

Infants older than one year, families who do not receive the home-visiting intervention, or those living outside the WakeMed service area would not directly receive the program benefits.

What this research studies

If you join, you and your baby would be randomly assigned to receive Promoting First Relationships® home visits or usual care. Trained providers will coach parents to be more responsive and collect small biological samples from infants to measure telomere length and epigenetic age. The team plans to enroll about 250 families through WakeMed pediatric clinics and follow infants during their first year. The goal is to learn whether strengthening parent–infant interactions can reduce early biological signs of aging.

Why it matters

Potential benefit: If successful, this could show that parent-support home visits slow cellular aging in infants and potentially reduce risk for later health problems.

How similar studies have gone: Previous home-visiting programs have improved parent sensitivity and child outcomes, but few randomized trials have measured effects on infant telomere length or epigenetic aging, so this application is relatively novel.

Where this research is happening

  • University of Washington
    Seattle, United States
    Active

Researchers

  • Principal investigator: Oxford, Monica L — University of Washington
  • Study coordinator: Oxford, Monica L

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.